Statistics for A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium
Total visits
views | |
---|---|
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium | 0 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |